Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma

By Kramer K.   Cheung N.-K.V.   Gerald W.L.   LaQuaglia M.   Kushner B.H.   LeClerc J.-M.   LeSauter L.   Saragovi H.U.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2098-2100

Elsevier

Access to resources Recommend Favorite

Analysis of candidate gene co-amplification with MYCN in neuroblastoma

By George R.E.   Kenyon R.   McGuckin A.G.   Kohl N.   Kogner P.   Christiansen H.   Pearson A.D.J.   Lunec J.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2037-2042

Elsevier

Access to resources Recommend Favorite

Expression of a 260kDa Neuroblastoma Surface Antigen, the Target of Cytotoxic Natural Human IgM: Correlation to MYCN Amplification and Effects of Retinoic Acid

By David K.   Ehrhardt A.   Ollert M.W.   Erttmann R.   Bredehorst R.   Vogel C.-W.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1937-1941

Elsevier

Access to resources Recommend Favorite

Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma

By Norris M.D.   Bordow S.B.   Haber P.S.   Marshall G.M.   Kavallaris M.   Madafiglio J.   Cohn S.L.   Salwen H.   Schmidt M.L.   Hipfner D.R.   Cole S.P.C.   Deeley R.G.   Haber M.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1911-1916

Elsevier

Access to resources Recommend Favorite

Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers

By                

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2415-2421

Spandidos Publications

Access to resources Recommend Favorite